Molecular remission is an independent predictor of progression-free survival in patients with Waldenström macroglobulinemia treated with chemo-immunotherapy: Results from the FIL_BIOWM study

Affiliations

• ¹ Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
• ² Department of Hematology, University Hospital "Ospedale di Circolo e Fondazione Macchi - ASST Sette Laghi", Varese, Italy.
• ³ Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy.
• ⁴ Department of Hematology, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), Salamanca, Spain.
• ⁵ Unit of Anatomic Pathology, University of Insubria, Varese, Italy.
• ⁶ UOS Clinical Epidemiology and Biostatistic, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
• ⁷ Department of Molecular Medicine, University of Pavia, Pavia, Italy.
• ⁸ Hematology, A.O.U. Città della Salute e della Scienza, University of Torino, Torino, Italy.